Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Dickson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pharmacology|February 4, 2014
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushingTaku Sakurai, Richard Davenport, Stuart Stafford, et al.
ACS Medicinal Chemistry Letters|May 15, 2024
Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical AssessmentRoland W Bürli, Kevin J Doyle, Louise Dickson, et al.
Journal of Medicinal Chemistry|August 31, 2023
Discovery of <b>CVN417</b>, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor DysfunctionLouisa A Christie, Nicola L Brice, Anna Rowland, et al.
Journal of Medicinal Chemistry|September 14, 2023
Discovery and Characterization of Novel CNS-Penetrant GPR55 AgonistsRichard C Hewer, Louisa A Christie, Kevin J Doyle, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Discovery of <b>CVN636</b>: A Highly Potent, Selective, and CNS Penetrant mGluR<sub>7</sub> Allosteric AgonistLouise Dickson, Martin Teall, Elodie Chevalier, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2022
Synthesis and SAR of novel GPR39 agonists and positive allosteric modulatorsRussell Burley, Richard C Hewer, Martin Teall, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 2, 2021
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L Brice, Hans H Schiffer, Holger Monenschein, et al.
Frontiers in Neuroscience|September 17, 2025
NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasiaGiuliano G Stirparo, Xiao Xu, Toni Thompson, et al.
Neuropharmacology|November 14, 2022
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pharmacology|February 4, 2014
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushingTaku Sakurai, Richard Davenport, Stuart Stafford, et al.
ACS Medicinal Chemistry Letters|May 15, 2024
Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical AssessmentRoland W Bürli, Kevin J Doyle, Louise Dickson, et al.
Journal of Medicinal Chemistry|August 31, 2023
Discovery of <b>CVN417</b>, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor DysfunctionLouisa A Christie, Nicola L Brice, Anna Rowland, et al.
Journal of Medicinal Chemistry|September 14, 2023
Discovery and Characterization of Novel CNS-Penetrant GPR55 AgonistsRichard C Hewer, Louisa A Christie, Kevin J Doyle, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 InhibitorsAndrew J Stott, Roland W Bürli, Kevin J Doyle, et al.
ACS Medicinal Chemistry Letters|April 20, 2023
Discovery of <b>CVN636</b>: A Highly Potent, Selective, and CNS Penetrant mGluR<sub>7</sub> Allosteric AgonistLouise Dickson, Martin Teall, Elodie Chevalier, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2022
Synthesis and SAR of novel GPR39 agonists and positive allosteric modulatorsRussell Burley, Richard C Hewer, Martin Teall, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 2, 2021
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L Brice, Hans H Schiffer, Holger Monenschein, et al.
Frontiers in Neuroscience|September 17, 2025
NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasiaGiuliano G Stirparo, Xiao Xu, Toni Thompson, et al.
Neuropharmacology|November 14, 2022
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasomeBernardino Ossola, Ali Rifat, Anna Rowland, et al.
Pageof 2